Skip to main content

IINN

Stock
Health Care
Medical Devices

Performance overview

IINN Price
Price Chart

Forward-looking statistics

Beta
0.68
Risk
75.10%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Company info

SectorHealth Care
IndustryMedical Devices
Employees24
Market cap$36.1M

Fundamentals

Enterprise value$15.3M
Revenue$0.0
Revenue per employee
Profit margin0.00%
Debt to equity15.30

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.60
Dividend per share
Revenue per share
Avg trading volume (30 day)$2M
Avg trading volume (10 day)$2M
Put-call ratio

Macro factor sensitivity

Growth+10.4
Credit-5.1
Liquidity-2.3
Inflation+8.8
Commodities+4.5
Interest Rates-3.1

Valuation

Dividend yield0.00%
PEG Ratio-1.70
Price to sales
P/E Ratio-1.70
Enterprise Value to Revenue
Price to book6.69

Upcoming events

Next earnings dayJanuary 8, 2024
Next dividend day
Ex. dividend day

News

Inspira Stock to Gain From its Appearance at Annual ELSO Conference

At the 34th annual ELSO conference in Detroit, IINN will present its FDA-cleared latest and future technology, the INSPIRA ART100 system.

Zacks Investment Research (September 25, 2024)
Why Inspira Technologies Stock Soared Today

Inspira Technologies Oxy BHN Ltd (NASDAQ: IINN) shares closed up76.6% at $2.19 Wednesday after the company announced it developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition. Inspira's blood sensor, HYLA, is.

Benzinga (July 6, 2022)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free